Search

everythinglearnresearchcommunity

for

Search:↓

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Combining low-level laser therapy and exosome therapy promotes hair growth.

Short-term side effects of low-dose radioactive iodine therapy are common but temporary.

Laser hair removal improves quality of life but emotional benefits decrease over time, suggesting more treatments are needed for lasting effects.

The document's content couldn't be understood or processed.

Lupus severely affects daily life, work, and mental health, with many experiencing frequent flares and medication side-effects.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Low-Level Laser Therapy might be a good alternative for hair loss when other treatments fail, but its effectiveness varies and more research is needed.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

TRPS1 is crucial for bone, kidney, and hair follicle development.

Solid Lipid Particle technology makes retinol more stable, effective, and gentle on the skin.

Patients with limited English prefer professional language interpretation in otolaryngology clinics.

The ABHRS has outlined its goals for the next year.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

People with weakened immune systems, like those with SLE, are at higher risk for TB.

The patient responded well to treatment with no disease progression.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Traditional Persian medicine helped a woman with resistant hyperthyroidism improve and stabilize her condition.